SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 167 filers reported holding SAGE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,825,000 | -49.9% | 20,000 | -44.4% | 0.60% | -44.3% |
| Q2 2018 | $5,635,000 | -68.2% | 36,000 | -67.3% | 1.07% | -78.1% |
| Q1 2018 | $17,718,000 | +115.1% | 110,000 | +120.0% | 4.89% | +40.1% |
| Q4 2017 | $8,236,000 | +257.6% | 50,000 | 0.0% | 3.49% | +331.0% |
| Q3 2016 | $2,303,000 | – | 50,000 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |